Ascentage Pharma Group International (AAPG) Other Non-Current Liabilities: 2023-2024

  • Ascentage Pharma Group International's Other Non-Current Liabilities fell 66.16% to $860,000 in Q4 2024 from the same period last year, while for Dec 2024 it was $860,000, marking a year-over-year decrease of 66.16%. This contributed to the annual value of $860,000 for FY2024, which is 66.79% down from last year.
  • Per Ascentage Pharma Group International's latest filing, its Other Non-Current Liabilities stood at $860,000 for Q4 2024, which was down 66.16% from $2.5 million recorded in Q4 2023.
  • Over the past 5 years, Ascentage Pharma Group International's Other Non-Current Liabilities peaked at $2.5 million during Q4 2023, and registered a low of $860,000 during Q4 2024.
  • Moreover, its 2-year median value for Other Non-Current Liabilities was $1.7 million (2023), whereas its average is $1.7 million.
  • Data for Ascentage Pharma Group International's Other Non-Current Liabilities shows a maximum YoY tumbled of 66.16% (in 2024) over the last 5 years.
  • Over the past 2 years, Ascentage Pharma Group International's Other Non-Current Liabilities (Quarterly) stood at $2.5 million in 2023, then plummeted by 66.16% to $860,000 in 2024.